NMD4C Launch Third Annual Training Series for Clinical Neuromuscular Fellows
The NMD4C Clinical Research Curriculum Development team is pleased to share that the third annual National Neuromuscular Lecture Series began this past August.
The NNLS is a year-long educational curriculum that provides training for clinical fellows enrolled in a Canadian neuromuscular fellowship program. The curriculum provides lectures from national experts in 32 key neuromuscular topics, developed in consultation with the directors of fellowship programs across Canada. The lecture series is designed to offer neuromuscular fellows at Canadian institutions the chance to learn from experts in different disciplines of neuromuscular medicine and forge connections with senior clinicians and investigators from across the country. The NNLS is approved by the Royal College of Physicians and Surgeons as a group learning activity as defined by the Maintenance of Certification Program, and fellows who attend over 75% of the lectures receive a certificate of attendance from the NMD4C.
In addition to lectures, this year’s program will also offer further engagement opportunities for participants as we introduce novel sessions in the form of journal club discussions, case presentations, and debates on emerging topics in neuromuscular medicine. The NNLS also offers opportunities for former fellows to stay involved in educational initiatives, and we are pleased to welcome Drs. Marianne Nury, Alasdair Rathbone, Issa Alawneh, Amanda Yaworski, Mona Hnaini, and Djurdja Djordjevic as moderators for this year’s program! They are joined by senior clinicians Drs. Alberto Aleman, Hernan Gonorazky, Erin O’Ferrall, Shahin Khayambashi and Jessica Theriault.
To learn more about the lecture series, please contact NNLS lead Dr. Alberto Aleman, or NDM4C Training and Curriculum coordinator Victoria Larocca.
Read next...
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.
New Best Practice Recommendations for SBMA Care in Canada
Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!
Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting
On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.
NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.
2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!
Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.